Format

Send to

Choose Destination
Leukemia. 2017 Sep;31(9):2005-2008. doi: 10.1038/leu.2017.195. Epub 2017 Jun 20.

Recurrent cyclin D2 mutations in myeloid neoplasms.

Khanna V1,2,3, Eide CA1,4,5, Tognon CE1,4,5, Maxson JE1,4,6, Wilmot B1,7, Bottomly D1,7, McWeeney S1,7, Edwards V DK1,4,6, Druker BJ1,4,5, Tyner JW1,4,6.

Author information

1
Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
2
Howard Hughes Medical Research Fellows Program, Howard Hughes Medical Institute, Portland, OR, USA.
3
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
4
Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR, USA.
5
Howard Hughes Medical Institute, Portland, OR, USA.
6
Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, Portland, OR, USA.
7
Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health and Science University, Portland, OR, USA.
PMID:
28630439
PMCID:
PMC5763909
DOI:
10.1038/leu.2017.195
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center